JP2018528259A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018528259A5 JP2018528259A5 JP2018521714A JP2018521714A JP2018528259A5 JP 2018528259 A5 JP2018528259 A5 JP 2018528259A5 JP 2018521714 A JP2018521714 A JP 2018521714A JP 2018521714 A JP2018521714 A JP 2018521714A JP 2018528259 A5 JP2018528259 A5 JP 2018528259A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- nos
- growth
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims 15
- 241000124008 Mammalia Species 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 206010052428 Wound Diseases 0.000 claims 2
- 208000027418 Wounds and injury Diseases 0.000 claims 2
- 238000012217 deletion Methods 0.000 claims 2
- 230000037430 deletion Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 210000002919 epithelial cell Anatomy 0.000 claims 2
- 210000000981 epithelium Anatomy 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 210000000936 intestine Anatomy 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 238000007792 addition Methods 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 231100000481 chemical toxicant Toxicity 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 239000003440 toxic substance Substances 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15177017.9A EP3118216A1 (en) | 2015-07-16 | 2015-07-16 | Cellular growth and proliferation promoting peptides, and uses thereof |
| EP15177017.9 | 2015-07-16 | ||
| PCT/EP2016/067097 WO2017009490A1 (en) | 2015-07-16 | 2016-07-18 | Growth promoting peptides and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021008092A Division JP2021073238A (ja) | 2015-07-16 | 2021-01-21 | 成長促進性ペプチドおよびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018528259A JP2018528259A (ja) | 2018-09-27 |
| JP2018528259A5 true JP2018528259A5 (enExample) | 2019-08-22 |
Family
ID=53776325
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018521714A Pending JP2018528259A (ja) | 2015-07-16 | 2016-07-18 | 成長促進性ペプチドおよびその使用 |
| JP2021008092A Pending JP2021073238A (ja) | 2015-07-16 | 2021-01-21 | 成長促進性ペプチドおよびその使用 |
| JP2023171296A Pending JP2024001108A (ja) | 2015-07-16 | 2023-10-02 | 成長促進性ペプチドおよびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021008092A Pending JP2021073238A (ja) | 2015-07-16 | 2021-01-21 | 成長促進性ペプチドおよびその使用 |
| JP2023171296A Pending JP2024001108A (ja) | 2015-07-16 | 2023-10-02 | 成長促進性ペプチドおよびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US10905734B2 (enExample) |
| EP (5) | EP3118216A1 (enExample) |
| JP (3) | JP2018528259A (enExample) |
| KR (2) | KR102413624B1 (enExample) |
| CN (2) | CN113512102B (enExample) |
| AU (3) | AU2016293135B2 (enExample) |
| BR (1) | BR112018000655A2 (enExample) |
| CA (2) | CA3175595A1 (enExample) |
| DK (1) | DK3590523T3 (enExample) |
| ES (2) | ES2904459T3 (enExample) |
| MX (2) | MX376011B (enExample) |
| WO (3) | WO2017009489A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114650834A (zh) * | 2019-08-20 | 2022-06-21 | 努里塔斯有限公司 | 用于治疗肌肉萎缩的肽 |
| FR3114744B1 (fr) | 2020-10-02 | 2024-01-05 | Basf Beauty Care Solutions France Sas | Nouvelle utilisation d’un peptide pour améliorer le confort de la peau et/ou des muqueuses et/ou l’apparence des phanères |
| CN114315970B (zh) * | 2022-03-15 | 2022-07-19 | 中食都庆（山东）生物技术有限公司 | 一种具有增肌作用的豌豆肽及其制备方法、药物和应用 |
| FR3141066A1 (fr) | 2022-10-24 | 2024-04-26 | Basf Beauty Care Solutions France Sas | Nouvelle utilisation d’un peptide pour améliorer la matrice extracellulaire du derme de la peau et/ou des muqueuses |
| EP4666996A1 (en) * | 2024-06-21 | 2025-12-24 | Quiris Healthcare GmbH & Co. KG | Composition containing peptides of vegetable origin |
| CN118834269B (zh) * | 2024-09-23 | 2025-02-11 | 天津科技大学 | 一种豌豆鲜味肽及其制备方法和应用 |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217344A (en) | 1976-06-23 | 1980-08-12 | L'oreal | Compositions containing aqueous dispersions of lipid spheres |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4186183A (en) | 1978-03-29 | 1980-01-29 | The United States Of America As Represented By The Secretary Of The Army | Liposome carriers in chemotherapy of leishmaniasis |
| US4261975A (en) | 1979-09-19 | 1981-04-14 | Merck & Co., Inc. | Viral liposome particle |
| US4485054A (en) | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4946787A (en) | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4774085A (en) | 1985-07-09 | 1988-09-27 | 501 Board of Regents, Univ. of Texas | Pharmaceutical administration systems containing a mixture of immunomodulators |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| AU7979491A (en) | 1990-05-03 | 1991-11-27 | Vical, Inc. | Intracellular delivery of biologically active substances by means of self-assembling lipid complexes |
| ES2103366T3 (es) | 1991-03-07 | 1997-09-16 | Novo Nordisk As | Hidrolizado proteico de guisante, metodo para su produccion y su utilizacion. |
| US5516642A (en) | 1992-11-16 | 1996-05-14 | Bristol-Myers Squibb Company | Polypeptides derived from major histocompatibility complex Class I antigen |
| JP2673659B2 (ja) | 1994-02-11 | 1997-11-05 | 株式会社ホーネンコーポレーション | ペプチド |
| US5688489A (en) | 1995-09-15 | 1997-11-18 | Resolution Pharmaceuticals, Inc. | Non-receptor mediated imaging agents |
| FR2751874B1 (fr) | 1996-08-02 | 1998-08-28 | Sederma Sa | Nouvelles compositions cosmetiques pour embellir et eclaircir la peau |
| US6372717B1 (en) | 1996-08-23 | 2002-04-16 | Sederma S.A. | Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions |
| FR2769502B1 (fr) | 1997-10-14 | 2000-04-14 | Sederma Sa | Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait vegetal obtenu a partir du trefle (trifolium sp.) |
| US20040031072A1 (en) | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
| IT1313572B1 (it) | 1999-07-27 | 2002-09-09 | Enichem Spa | Procedimento per la preparazione di epossidi. |
| US20110131679A2 (en) * | 2000-04-19 | 2011-06-02 | Thomas La Rosa | Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
| JP2001335596A (ja) * | 2000-05-24 | 2001-12-04 | Kenji Sakamoto | 新規ペプチド及びその医薬用途 |
| WO2002084250A2 (en) | 2001-04-17 | 2002-10-24 | Femtolink Biotechnologies Llc | Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples |
| AU2003290582A1 (en) * | 2002-11-04 | 2004-06-07 | Florida State University Research Foundation | NUCLEIC ACID AND ALLERGENIC POLYPEPTIDES ENCODED THEREBY IN CASHEW NUTS (Anacardium occidentale) |
| SE0300795D0 (sv) | 2003-03-24 | 2003-03-24 | Isconova Ab | Composition comprising iscom particles and live micro-organisms |
| CN1832755A (zh) | 2003-05-23 | 2006-09-13 | 佩斯特卡生物医疗实验室公司 | 使用干扰素治疗严重急性呼吸综合征及其他病毒感染 |
| ES2381359T3 (es) | 2003-11-17 | 2012-05-25 | Sederma | Composiciones que contienen mezclas de tetrapéptidos y tripéptidos |
| US20070053845A1 (en) | 2004-03-02 | 2007-03-08 | Shiladitya Sengupta | Nanocell drug delivery system |
| CA2572765C (en) * | 2004-07-08 | 2013-05-21 | Amgen Inc. | Compound having improved bioefficiency when administered in a multidose regimen |
| EP1896496B1 (en) | 2005-06-29 | 2012-01-11 | Hadasit Medical Research Services & Development Ltd. | Protein kinase c inhibitors for prevention of insulin resistance and type 2 diabetes |
| US8105572B2 (en) | 2007-05-18 | 2012-01-31 | New York University | Method of treating tuberculosis with interferons |
| KR100759495B1 (ko) * | 2006-02-17 | 2007-09-18 | 재단법인서울대학교산학협력재단 | 친수성 생리활성 펩타이드와 소수성 물질을 포함한자기조립 나노구조체 |
| US8343531B2 (en) | 2006-04-21 | 2013-01-01 | Meiji Co., Ltd. | Composition containing peptide as active ingredient |
| EP2021363A4 (en) * | 2006-05-17 | 2010-02-03 | Dairy Australia Ltd | POLYPEPTIDES AND POLYNUCLEOTIDE CODING THEREFOR |
| US9034402B2 (en) | 2007-04-16 | 2015-05-19 | Solae, Llc | Protein hydrolysate compositions having improved sensory characteristics and physical properties |
| EP2840142B1 (en) * | 2007-06-06 | 2018-12-26 | Monsanto Technology LLC | Genes and uses for plant enhancement |
| JP2010537952A (ja) | 2007-08-24 | 2010-12-09 | マイレクサ ピーティーワイ リミテッド | 過敏症反応の調節因子 |
| EP2050437A1 (en) | 2007-10-15 | 2009-04-22 | Laboratoires SMB | Improved pharmaceutical dry powder compositions for inhalation. |
| WO2011122937A1 (en) * | 2010-03-29 | 2011-10-06 | N.V. Nutricia | Pea protein peptides with anti helicobacter pylori activity |
| ES2397890B1 (es) | 2011-03-25 | 2014-02-07 | Lipotec, S.A. | Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas. |
| EP2793605A1 (en) | 2011-12-21 | 2014-10-29 | Laboratorios Ordesa, S.L | Process for obtaining rice protein hydrolysates useful in the prevention and/or treatment of obesity |
| EP2897631A4 (en) | 2012-08-31 | 2016-10-05 | Univ Virginia Patent Found | TARGET PEPTIDES FOR IMMUNOTHERAPY AND DIAGNOSTICS |
| WO2014200910A2 (en) * | 2013-06-10 | 2014-12-18 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| WO2015054507A1 (en) * | 2013-10-10 | 2015-04-16 | Pronutria, Inc. | Nutritive polypeptide production systems, and methods of manufacture and use thereof |
| WO2016090252A1 (en) * | 2014-12-04 | 2016-06-09 | Mary Kay Inc. | Topical skin care composition comprising trifluoroacetyl tripeptide-2 |
| US20170183386A1 (en) | 2015-07-16 | 2017-06-29 | Nuritas Limited | Peptides, and uses thereof |
-
2015
- 2015-07-16 EP EP15177017.9A patent/EP3118216A1/en not_active Withdrawn
-
2016
- 2016-07-18 CN CN202110378674.5A patent/CN113512102B/zh active Active
- 2016-07-18 EP EP21192258.8A patent/EP3998276A3/en active Pending
- 2016-07-18 MX MX2018000699A patent/MX376011B/es active IP Right Grant
- 2016-07-18 WO PCT/EP2016/067096 patent/WO2017009489A1/en not_active Ceased
- 2016-07-18 WO PCT/EP2016/067097 patent/WO2017009490A1/en not_active Ceased
- 2016-07-18 BR BR112018000655-6A patent/BR112018000655A2/pt active Search and Examination
- 2016-07-18 WO PCT/EP2016/067092 patent/WO2017009486A1/en not_active Ceased
- 2016-07-18 DK DK19184361.4T patent/DK3590523T3/da active
- 2016-07-18 CA CA3175595A patent/CA3175595A1/en active Pending
- 2016-07-18 KR KR1020187004161A patent/KR102413624B1/ko active Active
- 2016-07-18 EP EP22208048.3A patent/EP4219521B1/en active Active
- 2016-07-18 CA CA2992382A patent/CA2992382C/en active Active
- 2016-07-18 ES ES19184361T patent/ES2904459T3/es active Active
- 2016-07-18 KR KR1020227021325A patent/KR102744262B1/ko active Active
- 2016-07-18 US US15/744,390 patent/US10905734B2/en active Active
- 2016-07-18 EP EP16751182.3A patent/EP3322429B8/en active Active
- 2016-07-18 ES ES22208048T patent/ES3035669T3/es active Active
- 2016-07-18 AU AU2016293135A patent/AU2016293135B2/en active Active
- 2016-07-18 JP JP2018521714A patent/JP2018528259A/ja active Pending
- 2016-07-18 EP EP19184361.4A patent/EP3590523B1/en active Active
- 2016-07-18 CN CN201680053432.6A patent/CN108135960A/zh active Pending
-
2018
- 2018-01-16 MX MX2020010807A patent/MX2020010807A/es unknown
-
2019
- 2019-07-08 US US16/504,872 patent/US10925922B2/en active Active
-
2021
- 2021-01-20 US US17/153,587 patent/US11707500B2/en active Active
- 2021-01-21 JP JP2021008092A patent/JP2021073238A/ja active Pending
- 2021-04-22 AU AU2021202478A patent/AU2021202478A1/en not_active Abandoned
-
2023
- 2023-06-06 US US18/330,109 patent/US20230355704A1/en not_active Abandoned
- 2023-10-02 JP JP2023171296A patent/JP2024001108A/ja active Pending
-
2024
- 2024-06-14 US US18/743,639 patent/US20250018001A1/en active Pending
- 2024-08-20 AU AU2024211009A patent/AU2024211009A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018528259A5 (enExample) | ||
| JP6159084B2 (ja) | 酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物 | |
| JP7330471B2 (ja) | 線維症の予防、改善または治療のためのｃｈｐ（シクロ－ヒスプロ）の用途 | |
| CN102846587B (zh) | 脂肪酸组合物和植物提取物与药物制剂及其应用 | |
| JP2020527134A5 (enExample) | ||
| TW201002334A (en) | Andrographis paniculata extract | |
| CN105142728A (zh) | 用于治疗表面创伤的组合物和方法 | |
| JP2015512386A5 (enExample) | ||
| JP2012524112A5 (enExample) | ||
| US20170183386A1 (en) | Peptides, and uses thereof | |
| Basu et al. | Toxicity with radiotherapy for oral cancers and its management: A practical approach | |
| MX2025005597A (es) | Compuestos antisenescencia novedosos y composiciones de los mismos | |
| WO2014129818A1 (ko) | 당뇨병성 창상의 예방 또는 치료용 약학 조성물 | |
| WO2017181978A1 (zh) | 贻贝粘蛋白产品及其抑制血管炎症的应用 | |
| JP6656890B2 (ja) | フィラグリン産生促進剤 | |
| US20170360882A1 (en) | Composition for preventing, improving or treating psoriasis comprising immunomodulator and glucosamine | |
| CN108619486B (zh) | 一种治疗皮肤病的软膏剂及其制备方法 | |
| CN104758305A (zh) | 三七皂苷Ft1的医药用途 | |
| WO2017088177A1 (zh) | 贻贝粘蛋白产品及其预防和抑制神经炎症的应用 | |
| RU2391995C1 (ru) | Средство для лечения злокачественных и доброкачественных новообразований различной локализации | |
| KR101574591B1 (ko) | 신곡 추출물을 포함하는 상처 치료용 조성물 | |
| JP2019529554A5 (enExample) | ||
| KR102405111B1 (ko) | 쇼가올을 이용한 철 항상성 유지 방법 | |
| CN106265112A (zh) | 促进伤口愈合的药物、化妆用组合物和食品添加剂 | |
| CN117122607A (zh) | 灯盏花素-rdg类肽合物在制备治疗冻伤导致肢端循环障碍和炎症药物中的应用 |